Mostrar el registro sencillo del ítem

resumen

Resumen
Parkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly, currently with no cure. Its mechanisms are not well understood, however α-synuclein protein aggregation plays a central role in the pathogenesis of PD, leading to neurodegeneration. We demonstrated that in a PD model dietary in Caenorhabditis elegans treatment with an extract from the rhizome of Canna coccinea decreased the accumulation of α-synuclein. The [ver mas...]
dc.contributor.authorSpotorno, Viviana Graciela
dc.contributor.authorRoxo, Mariana
dc.contributor.authorWetterauer, Bernhard
dc.contributor.authorZabal, Osvaldo Alfredo
dc.contributor.authorWink, Michael
dc.date.accessioned2025-02-24T11:02:02Z
dc.date.available2025-02-24T11:02:02Z
dc.date.issued2025-03
dc.identifier.issn0367-326X
dc.identifier.issn1873-6971
dc.identifier.otherhttps://doi.org/10.1016/j.fitote.2025.106380
dc.identifier.urihttp://hdl.handle.net/20.500.12123/21418
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/S0367326X2500005X
dc.description.abstractParkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly, currently with no cure. Its mechanisms are not well understood, however α-synuclein protein aggregation plays a central role in the pathogenesis of PD, leading to neurodegeneration. We demonstrated that in a PD model dietary in Caenorhabditis elegans treatment with an extract from the rhizome of Canna coccinea decreased the accumulation of α-synuclein. The extract showed low toxicity to neuro 2a cells and protected them from oxidative damage with H2O2 as a model for neurodegeneration. We studied the chemical profile of the extract using liquid chromatography couple to Mass Spectrometry. In order to characterize the herbal extract, we quantified rosmarinic acid as a marker compound and measured its antioxidant activity in vitro. Altogether, apart from its potential as a functional food, Canna coccinea may be an interesting source of secondary metabolites in the development of potential novel anti-neurodegenerative drugs.eng
dc.formatapplication/pdfes_AR
dc.language.isoenges_AR
dc.publisherElsevieres_AR
dc.relationinfo:eu-repograntAgreement/INTA/PNHFA-1106094/AR./Plataformas tecnológicas y comerciales, para aromáticas cultivadas-nativas y medicinaleses_AR
dc.rightsinfo:eu-repo/semantics/restrictedAccesses_AR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/es_AR
dc.sourceFitoterapia 181 : 106380. (March 2025)es_AR
dc.subjectCannaeng
dc.subjectExtractos Vegetaleses_AR
dc.subjectPlant Extractseng
dc.subjectTrastornos del Sistema Nerviosoes_AR
dc.subjectNervous System Diseaseseng
dc.subjectCaenorhabditis eleganseng
dc.subjectNeuropatiaes_AR
dc.subjectNeuropathyeng
dc.subject.otherCanna coccineaes_AR
dc.titleEffects on neuroprotection and α-synuclein expression of a Canna coccinea rhizome extractes_AR
dc.typeinfo:ar-repo/semantics/artículoes_AR
dc.typeinfo:eu-repo/semantics/articlees_AR
dc.typeinfo:eu-repo/semantics/publishedVersiones_AR
dc.rights.licenseCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)es_AR
dc.description.origenInstituto de Recursos Biológicoses_AR
dc.description.filFil: Spotorno, Viviana Graciela. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Recursos Biológicos; Argentinaes_AR
dc.description.filFil: Roxo, Mariana. Heidelberg University. Institute of Pharmacy and Molecular Biotechnology; Alemaniaes_AR
dc.description.filFil: Wetterauer, Bernhard. Heidelberg University. Institute of Pharmacy and Molecular Biotechnology; Alemaniaes_AR
dc.description.filFil: Zabal, Osvaldo Alfredo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina.es_AR
dc.description.filFil: Wink, Michael. Heidelberg University. Institute of Pharmacy and Molecular Biotechnology; Alemaniaes_AR
dc.subtypecientifico


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

common

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess